Parthenolide was reported to induce robust apoptosis in total as well as more primitive CD34+ populations from primary human AML specimens representing different French-American-British (FAB) subtypes while sparing normal hematopoietic cells. The gene discussed is CD34; the disease is acute myeloid leukemia.